193 related articles for article (PubMed ID: 31772083)
1. Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study.
Klumper J; Breebaart W; Roos C; Naaktgeboren CA; van der Post J; Bosmans J; van Kaam A; Schuit E; Mol BW; Baalman J; McAuliffe F; Thornton J; Kok M; Oudijk MA
BMJ Open; 2019 Nov; 9(11):e029101. PubMed ID: 31772083
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).
Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HC; Bloemenkamp KW; Bolte AC; Cornette J; Derks JB; Duvekot JJ; van Eyck J; Kwee A; Opmeer BC; van Pampus MG; Lotgering FK; Scherjon SA; Sollie KM; Spaanderman ME; Willekes C; van der Post JA; Mol BW
BMC Pregnancy Childbirth; 2009 Sep; 9():38. PubMed ID: 19723320
[TBL] [Abstract][Full Text] [Related]
4. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).
Roos C; Scheepers LH; Bloemenkamp KW; Bolte A; Cornette J; Derks JB; Duvekot HJ; van Eyck J; Kok JH; Kwee A; Merién A; Opmeer BC; van Pampus MG; Papatsonis DN; Porath MM; van der Post JA; Scherjon SA; Sollie K; Spaanderman ME; Vijgen SM; Willekes C; Mol BW; Lotgering FK
BMC Pregnancy Childbirth; 2009 Sep; 9():42. PubMed ID: 19737426
[TBL] [Abstract][Full Text] [Related]
5. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
Lorthe E; Kayem G;
BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
van Vliet EOG; Nijman TAJ; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KWM; Scheepers HCJ; Jacquemyn Y; Beek EV; Duvekot JJ; Franssen MTM; Papatsonis DN; Kok JH; van der Post JAM; Franx A; Mol BW; Oudijk MA
Lancet; 2016 May; 387(10033):2117-2124. PubMed ID: 26944026
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
[TBL] [Abstract][Full Text] [Related]
8. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue.
Romero R; Sibai BM; Sanchez-Ramos L; Valenzuela GJ; Veille JC; Tabor B; Perry KG; Varner M; Goodwin TM; Lane R; Smith J; Shangold G; Creasy GW
Am J Obstet Gynecol; 2000 May; 182(5):1173-83. PubMed ID: 10819855
[TBL] [Abstract][Full Text] [Related]
9. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
[TBL] [Abstract][Full Text] [Related]
10. Acute tocolysis for uterine tachysystole or suspected fetal distress.
Leathersich SJ; Vogel JP; Tran TS; Hofmeyr GJ
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009770. PubMed ID: 29971813
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).
Hermans FJ; Schuit E; Opmeer BC; Oudijk MA; Bekker M; Woiski M; Bax CJ; Sueters M; Scheepers HC; Franssen MT; Pajkrt E; Mol BW; Kok M
BMC Pregnancy Childbirth; 2016 Jul; 16(1):154. PubMed ID: 27405353
[TBL] [Abstract][Full Text] [Related]
12. Tocolysis with nifedipine versus atosiban and perinatal outcome: an individual participant data meta-analysis.
van Winden TMS; Nijman TAJ; Kleinrouweler CE; Salim R; Kashanian M; Al-Omari WR; Pajkrt E; Mol BW; Oudijk MA; Roos C
BMC Pregnancy Childbirth; 2022 Jul; 22(1):567. PubMed ID: 35840927
[TBL] [Abstract][Full Text] [Related]
13. Effect of nifedipine and atosiban on perinatal brain injury: secondary analysis of the APOSTEL-III trial.
Nijman TAJ; Goedhart MM; Naaktgeboren CN; de Haan TR; Vijlbrief DC; Mol BW; Benders MJN; Franx A; Oudijk MA
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):806-812. PubMed ID: 28452086
[TBL] [Abstract][Full Text] [Related]
14. [Tocolysis for preterm labor without premature preterm rupture of membranes].
Doret M; Kayem G
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1374-1398. PubMed ID: 28029463
[TBL] [Abstract][Full Text] [Related]
15. [Tocolysis in preterm labour--current recommendations].
Wielgoś M; Bomba-Opoń DA
Ginekol Pol; 2014 May; 85(5):332-4. PubMed ID: 25011212
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin receptor antagonists for inhibiting preterm labour.
Papatsonis D; Flenady V; Cole S; Liley H
Cochrane Database Syst Rev; 2005 Jul; (3):CD004452. PubMed ID: 16034931
[TBL] [Abstract][Full Text] [Related]
17. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
Roos C; Spaanderman ME; Schuit E; Bloemenkamp KW; Bolte AC; Cornette J; Duvekot JJ; van Eyck J; Franssen MT; de Groot CJ; Kok JH; Kwee A; Merién A; Nij Bijvank B; Opmeer BC; Oudijk MA; van Pampus MG; Papatsonis DN; Porath MM; Scheepers HC; Scherjon SA; Sollie KM; Vijgen SM; Willekes C; Mol BW; van der Post JA; Lotgering FK;
JAMA; 2013 Jan; 309(1):41-7. PubMed ID: 23280223
[TBL] [Abstract][Full Text] [Related]
18. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
[TBL] [Abstract][Full Text] [Related]
19. Tocolysis compared with no tocolysis in women with threatened preterm birth and ruptured membranes: A propensity score analysis.
van Winden TMS; Roos C; Nijman TAJ; Kleinrouweler CE; Olaru A; Mol BW; McAuliffe FM; Pajkrt E; Oudijk MA
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():67-73. PubMed ID: 33096392
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
Worldwide Atosiban versus Beta-agonists Study Group
BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
